Israeli Legislation.com
RegulationsTax Law

Income Tax (Restructuring of Research and Development-Intensive Companies) Regulations, 5754-1994

תקנות מס הכנסה (שינוי מבנה של חברות עתירות מחקר ופיתוח), תשנ"ד-1994

Published: 1994-08-18Consolidated Hebrew text as of 2008-01-01 · Last amended 2020-05-21
Premium
Unofficial English translation — for reference only. It may contain errors or omissions and cannot be relied on as a legal text. Only the Hebrew text published in Reshumot is legally binding.More

This English text was translated from the official Hebrew using a range of translation tools, and it undergoes ongoing checks and updates. It is not a certified translation.

Despite these checks, it may contain errors, omissions, or imprecise renderings of legal terminology and cross-references, and it may not yet reflect the latest amendments. It cannot be relied upon as a legal text.

The Hebrew text as published in Reshumot (ספר החוקים) and on the Knesset website is the sole authoritative and legally binding version. In any discrepancy, the Hebrew text prevails.

This translation is provided for informational purposes only and does not constitute legal advice. For use in legal proceedings, request a certified Expert Legal Opinion.

By virtue of my authority under Section 103a(b) of the Income Tax Ordinance (hereinafter – the Ordinance), and with the approval of the Finance Committee of the Knesset, I hereby make these Regulations:

Definitions§

1.

In these Regulations –

"research and development-intensive company" – a company resident in Israel in respect of which all of the following conditions are met:

(1)the principal activity thereof from the day on which it was incorporated, and if it was incorporated more than two years before the restructuring – in the two years preceding the restructuring, is research and development activity (hereinafter – the period preceding the restructuring);
(2)the principal activity thereof for at least two years from the date of the restructuring is research and development activity, or the use of products developed by means of research and development carried out by it or the marketing of such products;
(3)all of the company's assets were used during the periods prescribed in paragraphs (1) and (2) (hereinafter – the research and development period) directly or indirectly for research and development activity, or were designated for use in such activity or in the use of the results of research and development carried out in the period preceding the restructuring;
(4)at least 75% of the research and development expenses incurred by the company during the research and development period were incurred in Israel, or a lower rate determined by the Commissioner, in consultation with the Chief Scientist as defined in the Law for the Encouragement of Research and Development in Industry, 5744-1984 (hereinafter – the R&D Encouragement Law), if expenses were incurred in respect of clinical and toxicological trials that cannot be carried out in Israel;
(5)the company did not hold rights in real property or rights in a real property association for at least two years from the date of the restructuring, except for such rights in real property used for the research and development, where it is not possible to carry out the research and development without the use of those rights;
(6)the Commissioner's approval has been given that the company meets the conditions of this definition;
(7)the consideration from an issuance of rights in the company and also in the company to which the company's rights were transferred (both hereinafter – the research companies), as the case may be, which is carried out within two years from the date of the restructuring, shall be used for investment in research and development; for this purpose, the company's expenses for the marketing of products developed by means of research and development that it carried out shall be regarded as investment in research and development, in an amount not exceeding 75% of the issuance consideration, provided that the amount of such expenses or the aggregate amount of the company's chargeable income in the year of the issuance and in the two tax years following it, whichever is the lower, shall be invested in research and development before the end of the third tax year following the year of the issuance, and the income of a controlling shareholder as defined in section 3(i) of the Ordinance whose source is the company shall also be regarded as the company's chargeable income;

"research and development", "research" or "development" – as defined in the R&D Encouragement Law, and also the transitional stages to production and marketing by the company of products developed by means of research and development that it carried out, all where the State or a body on its behalf participates in the financing of the research by means of a grant as defined in section 20a of the Ordinance, or where the Chief Scientist has approved that the research and development are as defined in the R&D Encouragement Law;

"research and development expenses" – all expenses incurred for research and development, whether in Israel or outside Israel;

"investment in research and development" – research and development expenses, including the investment of the issuance consideration in a deposit in Israeli currency or in foreign currency or in bonds of the State of Israel, if all of the following conditions are met in respect thereof:

(1)it was made immediately upon receipt of the consideration;
(2)it is entirely in a single deposit;
(3)for as long as it was in the deposit, no action was taken in respect of the investment, except for the withdrawal of funds from the deposit that were used immediately after their withdrawal for research and development expenses;
(4)the deposit is in the name of one of the research companies, it includes all investment profits, and it is held by an authorised dealer as defined in the Currency Control Law, 5738-1978, or by a banking corporation as defined in the Banking (Licensing) Law, 5741-1981, or by a foreign banking corporation provided that the Commissioner's prior approval has been given in respect of the deposit therein, and provided that within 30 days from the day on which the deposit was made, notice thereof was given to the assessing officer with whom the company's file is maintained, specifying the date of receipt of the issuance consideration, the date of the deposit, the deposit number and the place where it is held; for this purpose, "foreign banking corporation" – a banking corporation in one of the countries listed in the First Schedule to the Currency Control Permit, 5738-1978;
(5)all funds in the deposit and profits accumulated therein shall be used for research and development expenses within 4 years of the date of issuance of the rights.

Allotment of Rights§

2.

Notwithstanding the provisions of Section 104d(1) of the Ordinance, with respect to a transferred asset that consists of rights in a research and development-intensive company or with respect to the transfer of an asset to a research and development-intensive company under Section 104a or 104b of the Ordinance, as the case may be, the following provisions shall apply:

(1)Notwithstanding the provisions of the opening passage of Section 104d(1), the rights of those who were, immediately after the transfer, holders of rights in the company to which the asset was transferred, shall not be less than 25% of each of the rights in the research and development-intensive company, whether directly or indirectly;
(2)the provisions of sub-paragraph (b) of Section 104d(1) of the Ordinance shall not apply to those who were holders of rights in the research and development-intensive company immediately after the transfer, or in the company holding rights in the research and development-intensive company, as the case may be;
(3)Notwithstanding the provisions of sub-paragraph (c) of Section 104d(1) of the Ordinance, the research companies shall be entitled to allot shares to a person who was not a holder of rights in the company before the allotment, without the percentage limitation set out in that sub-paragraph.

Merger of Research and Development-Intensive Companies (Amendment 5763-2003)§

2a.

In a merger in which all the participating companies are research and development-intensive companies, the following provisions shall apply:

(1)Notwithstanding the provisions of the opening passage of Section 103c(9) of the Ordinance, the rights of those who were holders of rights in the companies participating in the merger shall not be less than 25% of each of the rights in the absorbing company;
(2)the provisions of Section 103c(9)(a) of the Ordinance shall not apply;
(3)Notwithstanding the provisions of Section 103c(9)(b) of the Ordinance, the absorbing company shall be entitled to allot shares to a person who was not a holder of rights in the company before the allotment, without the percentage limitation specified in that sub-paragraph.

Conditions for Eligibility§

3.

The research companies shall be eligible for the reliefs set out in these Regulations if all of the following conditions are met:

(1)they maintained, in the tax year preceding the restructuring and in the two tax years following it, admissible books of account under the double-entry accounting system, and if the company is a company that is not resident in Israel – in accordance with the Commissioner's instructions;
(2)they maintained a separate system of accounts in respect of each research and development project;
(3)an auditor's opinion on the research companies' compliance with the conditions set out in these Regulations has been given in respect of each tax year, together with the filing of the return under Section 131 of the Ordinance for that year, in the form directed by the Commissioner;
(4)where rights in an asset have been transferred to a research and development-intensive company or in a research and development-intensive company as referred to in Section 104a or 104b of the Ordinance – the reliefs shall apply only if all the rights of the holders of rights in the asset or in the said company, as the case may be, have been transferred, and those rights constituted all the rights in the asset or the rights in the research and development-intensive company.

Conditions for Eligibility in the Case of a Merger (Amendment 5763-2003)§

3a.

In the case of a merger under regulation 2a, it is required that, in addition to the conditions set out in regulation 3, it shall also be the case that all the rights in the research and development assets were held by the companies participating in the merger.

Commencement§

4.

These Regulations shall commence from the 1994 tax year.

18 Av 5754 (26 July 1994) Avraham (Beiga) Shohat

Minister of Finance

RegulationsTax Law

תקנות מס הכנסה (שינוי מבנה של חברות עתירות מחקר ופיתוח), תשנ"ד-1994

Income Tax Restructuring R&D

R&D Intensive Companies Regulations

Research and Development Tax Restructuring

RD Companies Restructuring Regulations

Takkanot Mas Hachnasa RD

Income Tax RD Regulations 1994

Research Development Company Restructuring

Tax Restructuring Research Companies

RD Intensive Enterprises Regulations